Pharmacies get a delay on track-and-trace regs; Drugmakers assess supply issues in Greece;

> Pharmacies have won a four-month delay, to Nov. 1, 2015, for meeting new regulations for product tracing that were to take effect Wednesday. Story

> Supreme Court ruling raises questions about warrantless inspections of manufacturing sites. Blog post

> Drugmakers are trying to decide how to avoid shortages in Greece if the debt problems are not worked out. Story

> Celgene ($CELG) is buying a the complex in Summit, NJ vacated by Merck ($MRK), a 1.3 million-square-foot site that includes manufacturing capabilities and warehouses along with R&D facilities and administrative space. Story

> A California man has pleaded guilty to selling counterfeit Viagra and Cialis in the U.S. Release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.